Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, we aimed to determine the associations of risk factors of MDR-TB across different regions. Methods: A systematic review and meta-analysis was performed with Pubmed and Embase databases. Information was retrieved on 37 pre-defined risk factors of MDR-TB. We estimated overall Mantel-Haenszel odds ratio as a measure of the association. Results: Factors of previous TB disease and treatment are the most important risk factors associated with MDR-TB. There was also a trend towards increased risk of MDR-TB for patients 40 years and older, unemployed, lacking health insurance, smear positive, with non-completion and failure of TB treatment, showing ad...
In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...
OBJECTIVE: To determine the risk factors for developing multidrug resistant tuberculosis in Banglade...
To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh.This cas...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
Abdulhalik Workicho, Wondwosen Kassahun, Fessahaye Alemseged Department of Epidemiology, C...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
BackgroundMultidrug-resistant tuberculosis (MDR-TB) is a growing public health concern globally. In ...
Abstract Background Multidrug-resistant tuberculosis (MDR-TB) is resistant to the two main first-lin...
The coronavirus disease 2019 (COVID-19) pandemic is affecting tuberculosis (TB) treatment in many wa...
This case control study was conducted in selected centers of Dhaka City from March to July 2008 to d...
Background: MDR-TB is a major threat to global TB control. In 2015, 580,000 were treated for MDR-TB ...
Background; Despite an overall decreasing incidence and mortality rate for tuberculosis (TB), multid...
Abstract Background Multidrug resistant (MDR) tuberculosis (TB) represents TB which is simultaneous ...
In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...
OBJECTIVE: To determine the risk factors for developing multidrug resistant tuberculosis in Banglade...
To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh.This cas...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Objectives: Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the setting, w...
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant t...
Abdulhalik Workicho, Wondwosen Kassahun, Fessahaye Alemseged Department of Epidemiology, C...
Among first line anti-TB drugs, Rifampicin (RMP) and Isoniazid (INH) are considered the most potent ...
BackgroundMultidrug-resistant tuberculosis (MDR-TB) is a growing public health concern globally. In ...
Abstract Background Multidrug-resistant tuberculosis (MDR-TB) is resistant to the two main first-lin...
The coronavirus disease 2019 (COVID-19) pandemic is affecting tuberculosis (TB) treatment in many wa...
This case control study was conducted in selected centers of Dhaka City from March to July 2008 to d...
Background: MDR-TB is a major threat to global TB control. In 2015, 580,000 were treated for MDR-TB ...
Background; Despite an overall decreasing incidence and mortality rate for tuberculosis (TB), multid...
Abstract Background Multidrug resistant (MDR) tuberculosis (TB) represents TB which is simultaneous ...
In 2015, 10.4 million people developed tuberculosis (TB) and 580,000 amongst them suffered from mult...
OBJECTIVE: To determine the risk factors for developing multidrug resistant tuberculosis in Banglade...
To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh.This cas...